REGN Regeneron Pharmaceuticals PE ratio, current and historical analysis

As of Mar 18, 2025, the Regeneron Pharmaceuticals stock's PE ratio is 16.26. This takes into account the latest EPS of $40.9 and stock price of $664.96. The PE ratio marks a decrease of 31% from its last 4 quarters average of 23.6.

REGN PE ratio history

How has REGN's PE ratio performed in the past

The PE ratio of Regeneron Pharmaceuticals has averaged 32.05 over the last ten years. The current P/E ratio of 16.26 is 49% lower than the historical average. Looking back at the last ten years, REGN's PE ratio peaked in the Mar 2015 quarter at 132.01, when the price was $451.48 and the EPS was $3.42. The lowest point was in the Dec 2021 quarter, when it reached 8.27 with a price of $631.52 and an EPS of $76.4.

Today
16.29
Average
32.05
Median
23.09
Minimum
8.27
Maximum
132.01

Regeneron Pharmaceuticals PE ratio by year

Maximum annual increase: 201.25% in 2013

Maximum annual decrease: -51.21% in 2016

Year PE ratio PE change Price EPS
2024 17.42 -26.53% $712.33 $40.9
2023 23.71 33.13% $878.29 $37.05
2022 17.81 115.36% $721.49 $40.51
2021 8.27 -44.12% $631.52 $76.4
2020 14.8 -23.59% $483.11 $32.65
2019 19.37 17.47% $375.48 $19.38
2018 16.49 -50.57% $373.5 $22.65
2017 33.36 -22.29% $375.96 $11.27
2016 42.93 -51.21% $367.09 $8.55
2015 87.99 -27.94% $542.87 $6.17
2014 122.1 87.64% $410.25 $3.36
2013 65.07 201.25% $275.24 $4.23
2012 21.6 N/A $171.07 $7.92
2011 N/A N/A $55.43 -$2.45
2010 N/A N/A $32.83 -$1.26

Regeneron Pharmaceuticals PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Dec 2024 17.42 -28.34% $712.33 $40.9
Sep 2024 24.31 -6.75% $1,051.24 $43.24
Jun 2024 26.07 -2.18% $1,051.03 $40.32
Mar 2024 26.65 12.4% $962.49 $36.12
Dec 2023 23.71 7.67% $878.29 $37.05
Sep 2023 22.02 23.22% $822.96 $37.38
Jun 2023 17.87 -15.07% $718.54 $40.21
Mar 2023 21.04 18.14% $821.67 $39.06
Dec 2022 17.81 30.09% $721.49 $40.51
Sep 2022 13.69 23.56% $688.87 $50.31
Jun 2022 11.08 19.01% $591.13 $53.37
Mar 2022 9.31 12.58% $698.42 $74.98
Dec 2021 8.27 -9.42% $631.52 $76.4
Sep 2021 9.13 -3.69% $605.18 $66.28
Jun 2021 9.48 -24.7% $558.54 $58.89

REGN average PE ratio chart

What is the average PE ratio of REGN for the past years

REGN's current PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
19.25
5-year avg
17.54
10-year avg
32.05
15-year avg
37.88

REGN PE vs peers

What is REGN's PE ratio compared to its peers

REGN's PE ratio stands lower than its peer stocks JNJ and NVS, but it is higher than BIIB's. Regeneron Pharmaceuticals is currently trading at a lower PE ratio (16.26) than its peers average of 25.42.

Stock name PE ratio Market cap
BIIB Biogen Inc 12.68 $20.8B
REGN Regeneron Pharmaceuticals Inc 16.29 $72.83B
NVS Novartis AG 18.84 $220.24B
JNJ Johnson & Johnson 27.91 $392.42B
AMGN Amgen Inc 41.51 $169.93B
ALNY Alnylam Pharmaceuticals Inc N/A $32.84B

Frequently asked questions

What is Regeneron Pharmaceuticals's PE ratio?

REGN stock has a price to earnings ratio of 16.26 as of Mar 18, 2025.

What is the 3-year average PE ratio for Regeneron Pharmaceuticals (REGN)?

The 3-year average price to earnings ratio for REGN stock is 19.25.

What is the 5-year average PE ratio for Regeneron Pharmaceuticals (REGN)?

The 5-year average price to earnings ratio for REGN stock is 17.54.

What is the highest PE ratio for REGN?

Over the last ten years, the quarterly PE ratio reached its highest level at 132.01 in the Mar 2015 quarter.

How does the current PE ratio for REGN compare to its historical average?

REGN's price to earnings ratio is currently 49% below its 10-year historical average.

How is REGN's PE ratio calculated (Regeneron Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Mar 18, 2025), Regeneron Pharmaceuticals's share price is $664.96. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $40.9. Therefore, Regeneron Pharmaceuticals's PE ratio for today is 16.26. PE RATIO(16.26) = STOCK PRICE($664.96) / TTM EPS($40.9)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.